Definition of paclitaxel albumin-stabilized nanoparticle formulation

Page Options

	Quick Links


	Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports Science Serving People Learn more about NCI Español Información en español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate NCI Responds to Hurricanes The Nation's Investment in Cancer Research FY 2009 Cancer Trends Progress Report: 2007 Update Past Highlights

You CAN Quit Smoking Now!

Search for

Starts with

Contains

In English En español

paclitaxel albumin-stabilized nanoparticle formulation (PAK-lih-TAK-sil al-BYOO-min-STAY-bih-lized NA-noh-PAR-tih-kil for-myoo-LAY-shun)

A drug used to treat breast cancer that has spread or that has come back within 6 months after chemotherapy. It is also being studied in the treatment of newly diagnosed breast cancer and other types of cancer. Paclitaxel albumin-stabilized nanoparticle formulation is a type of mitotic inhibitor. Also called nanoparticle paclitaxel, protein-bound paclitaxel, Abraxane, and ABI-007.

Previous Definitions:	p53 gene, pacemaker, Pacific valerian, pack year, paclitaxel
Next Definitions:	paclitaxel liposome, paclitaxel poliglumex, paclitaxel polyglutamate, Paget disease of bone, Paget disease of the nipple